Your browser doesn't support javascript.
loading
Survival time of HIV-infected patients with cryptococcal meningitis.
Article in English | IMSEAR | ID: sea-41130
ABSTRACT

OBJECTIVE:

To study survival time and risk factors of mortality among HIV-infected patients who had cryptococcal meningitis.

DESIGN:

Retrospective cohort study. MATERIAL AND

METHOD:

Patients' medical records of those who had HIV-infection with newly diagnosed cryptoccocal meningitis between January 2002 and December 2004 were reviewed. Each patient was classified into one of two groups, according to their anti-retroviral status (ART).

RESULTS:

Five hundred and forty nine patients enrolled in the present study 281 (51.2%) in the ART+ group and 268 (48.8%) in the ART-group. The mean age was 33.4 +/- 6.9 years old in the ART + group and 33.6 +/- 7.0 years old in the ART-group. There were more male in both groups 207 males and 74 females in the ART+ group, and 195 males and 73 females in the ART-group. Baseline CD4 cell count of both groups was 20 (6-74) cells/mL and 24 (9-72) cells/ml. About 30% of both groups of patients experienced major opportunistic infection before cryptococcal meningitis. All patients were treated by standard amphotericin B for a 2-week duration followed by fluconazole for an additional 8 weeks. There were no differences of baseline characteristics between the two groups (p > 0.05). The survival rates at 12, 24, and 36 months were 92.8%, 87.4%, and 85.4% in the ART+ group and 55.3%, 42.2%, and 36.8% in the ART- group, respectively (p < 0.01). The median survival time in the ART- group was 15 months. From the Cox regression model, the hazard ratio for "not received ART" was 4.87 (95%CI = 2.48-9.44, p < 0.01).

CONCLUSION:

The present study demonstrated the substantial increasing of survival time of HIV-infected patients with cryptococcal meningitis by initiated ART even in a resource limited setting (no flucytosine, local combined antiretroviral drugs with NVP based regimens).
Subject(s)
Full text: Available Index: IMSEAR (South-East Asia) Main subject: Survival / Time Factors / Female / Humans / Male / Comorbidity / Fluconazole / HIV Infections / Amphotericin B / Retrospective Studies Type of study: Etiology study / Observational study / Prognostic study / Risk factors Language: English Year: 2007 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: IMSEAR (South-East Asia) Main subject: Survival / Time Factors / Female / Humans / Male / Comorbidity / Fluconazole / HIV Infections / Amphotericin B / Retrospective Studies Type of study: Etiology study / Observational study / Prognostic study / Risk factors Language: English Year: 2007 Type: Article